News - Ten Bio

Your Skin Research Partner – Ten Bio

service /ˈsəːvɪs/ Noun: ‘the action of helping or doing work for someone’ A note from the Chair Ten Bio’s early experience with our anchor clients has had a very significant effect on how the company now operates. Through placing client interaction at the forefront of our priorities, the nature of the interaction between client and service provider has rapidly evolved to become that of a trusted ‘research partner’. As a research partner Ten Bio has developed services optimized to leverage the…

Ten Bio named finalist in Scotland’s Life Science award.

Ten Bio is proud to announce that our company has been named one of three finalists in Scotland’s Life Science award in the category ‘Innovation – Pharma Services and Drug Discovery’. Scotland’s Life Sciences Annual Awards showcase eight prestigious awards recognising a range of achievements including skills development, innovation, investment, innovative collaboration, and business leadership. The innovation in pharma services and drug discovery award will be presented to an organisation that has been responsible for the creation of an…

Happy Holidays

Happy Holidays and thank you for following Ten Bio this year!

The origins of TenSkin™

Entering our third year since spin out, it’s time to celebrate the origins of our technology which has brought Ten Bio early success in a range of markets. The origin of our invention story stems from Robyn Hickerson, our co-founder and CEO, and her work at the University of Dundee. In the course of her research on the development of therapeutics for rare skin diseases, Robyn utilized various skin models. These included animal, cell-based and ex vivo models, but all…

‘When I was two, I was nearly new’ ….

‘When I was two I was nearly new’ … with thanks to A. A. Milne for the line from his 1927 poem ‘Now we are Six’.Ten Bio is not six, but we are two and ‘nearly new’ and celebrate the second anniversary of our launch in September this year. It has been a fascinating journey so far and with much more to come. I am very much looking forward to the success we will achieve on the journey to .…

Our differentiation in wound management….

Our differentiation in wound management….a note from the Chair. In the previous note from the chairman I emphasized the potential role for Ten Bio in the area of wound management. My reason for that emphasis is simple: if you are evaluating how well a new approach / treatment can influence wound healing, then the key attribute of the test platform must be that it exhibits human skin’s normal response to wounding in vivo . . . or as close to…

Dr Paul Campbell seconded to Ten Bio through UK Medical Research Council Innovation Scholarship

Dr Paul Campbell, Reader in Physics at the University of Dundee has recently begun a secondment to Ten Bio through an Innovation Scholarship funded by the UK’s Medical Research Council.

Proud to be presenting at the Society for Investigative Dermatology Annual Meeting in Portland

May 18-21, 2022 We are proud to be exhibiting and presenting at the Society for Investigative Dermatology annual meeting later this week. Our Founder and CEO Robyn Hickerson will be describing how optimal tension in ex vivo skin models facilitates wound healing. Robyn who is co-inventor of Ten Bio’s tension-based ex vivo skin model and a group leader in the School of Life Sciences at the University of Dundee will be demonstrating how the application of an optimized tension to…

It’s just the start of Ten Bio’s journey…

A note from the Chair. I was introduced to Ten Bio’s founders in November 2019. I was immediately engaged by two things: firstly, the logic in support of the business proposition. When researching skin and how it reacts to challenges and treatments, surely you want to use a medium as close to living skin as can be achieved. And secondly the founders’ sheer enthusiasm for their technology and the differences that it could, even should, make to skin research. Animal…

Investment enables Ten Bio to establish new skin testing technology in USA

A near-£1 million investment will help University of Dundee spinout company Ten Bio Ltd to commercialise the human skin culture system it developed to provide a viable alternative for many experiments currently performed on animals. Led by TRICAPITAL LTD and with matched funding from Scottish Enterprise, the investment of £911,000 will enable the company to progress its mission to transform the testing of new pharmaceutical and cosmetic products. Initial launch of the company’s brand will be in the US, where…